Sumecigrel clinical trials
Also written vicagrel.
How each study uses sumecigrel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the sumecigrel studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test sumecigrel, phase 3 first.
- Dec 2026Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)Phase 3 · Jiangsu vcare pharmaceutical technology co., LTD
Studies
Open first, then newest update. How each study uses sumecigrel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)RecruitingPhase 3Jiangsu vcare pharmaceutical technology co., LTDNCT06577519Written as Vicagrel
- Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal MetabolizersCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT07067775Written as Vicagrel Capsules
- PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 MetabolizersCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT05162053Written as vicagrel Capsules
- Assessment of the Effect of Omeprazole on Vicagrel in Healthy SubjectsStatus unknownPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT05651074Written as Vicagrel and omeprazole
- A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult SubjectsCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT04919551Written as vicagrel
- The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy ManCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT04143750Written as [14C]Vicagrel
- The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for VicagrelCompletedPhase 2Jiangsu vcare pharmaceutical technology co., LTDNCT03599284Written as Vicagrel 5mg
- Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19CompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT03942458Written as Vicagrel 6mg
Codes
What other systems call sumecigrel · ClinicalTrials.gg INT006130
- UNII (FDA) 8A63K3TN0USUMECIGRELOne source FDA
- NCI Thesaurus C206992SumecigrelOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 8A63K3TN0U | SUMECIGREL | One source FDA |
| NCI Thesaurus | C206992 | Sumecigrel | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.